연구성과로 돌아가기

2020 연구성과별 연구자 정보 (790 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Yeh, Kun-Huei Yeh, KH 10 Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan HGD-3316-2022 Yeh, Kun-Huei 0000-0002-7306-174X YEH, Kun-Huei nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Yoshikawa, Takaki Yoshikawa, T 11 Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan Y-1580-2019 Yoshikawa, Takaki nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Yoshikawa, Takaki Yoshikawa, T 11 Natl Canc Ctr, Dept Gastr Surg, Tokyo, Japan Y-1580-2019 Yoshikawa, Takaki nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Oh, Sang Cheul Oh, SC 12 Korea Univ, Dept Internal Med, Div Hematol & Oncol, Coll Med, Seoul, South Korea nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Bai, Li-Yuan Bai, LY 13 China Med Univ, China Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Taichung, Taiwan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Tamura, Takao Tamura, T 14 Kindai Univ, Fac Med, Dept Med Oncol, Osaka, Japan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Tamura, Takao Tamura, T 14 Kindai Univ, Nara Hosp, Dept Med Oncol, Ikoma, Japan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Lee, Keun-Wook Lee, KW 15 Seoul Natl Univ, Bundang Hosp, Div Hematol & Oncol, Dept Internal Med,Coll Med, Seongnam, South Korea JQV-8143-2023 Lee, Juhyung nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Hamamoto, Yasuo Hamamoto, Y 16 Keio Univ, Keio Canc Ctr, Sch Med, Tokyo, Japan AAA-9941-2022 Hamamoto, Yasuo 0000-0002-5737-122X Hamamoto, Yasuo nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Kim, Jong Gwang Kim, JG 17 Kyungpook Natl Univ, Sch Med, Daegu, South Korea nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Chin, Keisho Chin, K 18 Hosp Japanese Fdn Canc Res, Inst Canc, Dept Gastroenterol, Tokyo, Japan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Oh, Do-Youn Oh, DY 19 Seoul Natl Univ, Seoul Natl Univ Hosp, Canc Res Inst, Dept Internal Med,Coll Med, Seoul, South Korea nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Minashi, Keiko Minashi, K 20 Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Cho, Jae Yong Cho, JY 21 Yonsei Univ, Gangnam Severance Hosp, Dept Med Oncol, Coll Med, Seoul, South Korea 0000-0002-0926-1819 Cho, Jae Yong nboku@ncc.go.jp;
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Tsuda, Masahiro Tsuda, M 22 Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan nboku@ncc.go.jp;
페이지 이동: